Literature DB >> 19577390

Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003.

F Berger1, V Goulet, Y Le Strat, J-C Desenclos.   

Abstract

BACKGROUND: Congenital toxoplasmosis may affect any organ, produce severe complications such as hydrocephalus and lead to ocular lesions which can appear late after birth. Fetal outcome can be fatal. During pregnancy, the mother can become infected, particularly by eating undercooked meat or poorly washed raw fruits and vegetables. In France, prevention of congenital toxoplasmosis is based on serial serology tests, performed repeatedly until delivery for pregnant women who remain negative then at the first prenatal visit.
METHODS: We used toxoplasmosis serology data collected during national perinatal surveys conducted in 1995 and 2003 to estimate toxoplasmosis prevalence, assess risk factors and ascertain time trends in prevalence. In each survey, socioeconomic variables as well as the serological status for toxoplasmosis were collected for all pregnant women who had terminated a pregnancy during a given week period.
RESULTS: In 2003, 15,108 pregnant women were included; the prevalence of Toxoplasma infection was 43.8% (95% CI: 43.0-44.6). Prevalence increased with age and was greater for those who lived in the Southwest of France, the greater Paris area and in overseas districts. In 2003, as in 1995, prevalence increased with education level, occupational status of the household and number of pregnancies. Prevalence decreased 19% between 1995 and 2003. The decrease was significantly greater for pregnant women aged less than 30 years than for those aged more or equal to 30 years.
CONCLUSION: Although it decreased over time, toxoplasmosis prevalence remained higher in France than in other European countries. With more than one out of two women in France susceptible of having Toxoplasma infection, it is important to promote preventive measures to avoid infection during pregnancy.

Entities:  

Mesh:

Year:  2009        PMID: 19577390     DOI: 10.1016/j.respe.2009.03.006

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  26 in total

Review 1.  Kinetics of Toxoplasma infection in the Balkans.

Authors:  Branko Bobić; Aleksandra Nikolić; Ivana Klun; Olgica Djurković-Djaković
Journal:  Wien Klin Wochenschr       Date:  2011-09-22       Impact factor: 1.704

2.  Discrepancies between a new highly sensitive Toxoplasma gondii ELISA assay and other reagents: interest of Toxo IgG Western blot.

Authors:  F Leslé; F Touafek; A Fekkar; D Mazier; L Paris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

Review 3.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Toxoplasmosis awareness, seroprevalence and risk behavior among pregnant women in the Gampaha district, Sri Lanka.

Authors:  Nilmini Chandrasena; Rasika Herath; Nawamalika Rupasinghe; Buddhini Samarasinghe; Hasaranga Samaranayake; Anuradhani Kastuririratne; Nilanthi Renuka de Silva
Journal:  Pathog Glob Health       Date:  2016-04-19       Impact factor: 2.894

5.  Seroprevalence and risk factors of Toxoplasma gondii infection in humans in East Hararghe Zone, Ethiopia.

Authors:  B Tilahun; Y Hailu; G Tilahun; H Ashenafi; M Vitale; V Di Marco; E Z Gebremedhin
Journal:  Epidemiol Infect       Date:  2015-06-15       Impact factor: 4.434

Review 6.  Toxoplasma gondii infection in humans in China.

Authors:  Peng Zhou; Zhaoguo Chen; Hai-Long Li; Haihong Zheng; Shenyi He; Rui-Qing Lin; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2011-08-24       Impact factor: 3.876

7.  Infection risk factors associated with seropositivity for Toxoplasma gondii in a population-based study in the Central Region, Ghana.

Authors:  E K Abu; J N Boampong; I Ayi; G Ghartey-Kwansah; R Afoakwah; P Nsiah; E Blay
Journal:  Epidemiol Infect       Date:  2014-11-06       Impact factor: 4.434

8.  Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation.

Authors:  F Nogareda; Y Le Strat; I Villena; H De Valk; V Goulet
Journal:  Epidemiol Infect       Date:  2013-11-14       Impact factor: 4.434

9.  A 4-year evaluation of toxoplasmosis seroprevalence in the general population and in women of reproductive age in central Italy.

Authors:  M Mosti; B Pinto; A Giromella; S Fabiani; R Cristofani; M Panichi; F Bruschi
Journal:  Epidemiol Infect       Date:  2012-12-11       Impact factor: 4.434

10.  Seroepidemiology of Toxoplasma gondii infection in the Israeli population.

Authors:  M Perry Markovich; T Shohat; I Riklis; R Avni; D Yujelevski-Rozenblit; R Bassal; D Cohen; E Rorman
Journal:  Epidemiol Infect       Date:  2013-04-15       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.